Skip to main content

Table 1 Baseline clinical and demographic characteristics of the patients

From: Troponin I as a mortality marker after lung resection surgery – a prospective cohort study

Variable

All patients

N = 151

%

Gender

 Male

58

38.4

Mean age (years)

55 ± 15

 

Weight (kg)

63 ± 12

 

Neoplastic etiology

116

76.8

Hypertensiona

51

33.8

Coronary diseaseb

3

2.0

Diabetes mellitusc

21

13.9

Smoking (current + ex-smokers)

84

56

Pack-years

19

±25

Previous radiotherapy

18

11.8

Previous chemotherapy

25

16.6

Functional capacity (MET)

  

< 4 MET

15

9.9

≥4 MET

136

90.1

EMAPO

 Low

125

82.8

 Moderate

23

15.2

 High

1

0.7

 Very high

2

1.3

ACP

 Class I

146

96.7

 Class II

5

3.3

 Class III

0

0

  1. MET Metabolic Equivalent, EMAPO Risk score by the Estudo Multicêntrico de Avaliação Perioperatória (Multicentric Perioperative Evaluation Study), ACP Detsky risk score (American College of Physicians)
  2. aSystolic blood pressure above 180 mmHg and/or diastolic blood pressure above 110 mmHg and/or patient who reports being hypertensive with or without the use of antihypertensive drugs
  3. bPatients with angina pectoris, previous history of myocardial infarction, or previous surgical and/or percutaneous procedures for myocardial revascularization
  4. cPatients who reported being diabetic with or without the use of medication or those who had a fasting serum glucose level > 126 mg/dl in preoperative tests
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us